The Urology Care Devices and Platforms Market Size is valued at USD 16.25 Bn in 2022 and is predicted to reach USD 33.05 Bn by the year 2031 at a 8.3% CAGR during the forecast period for 2023-2031.
The ageing population is more susceptible to urological conditions, increasing the need for urology care devices and platforms. Patients are increasingly requesting urology care platforms and devices due to growing awareness of urological problems and the value of early detection and treatment. Additionally, the recommendation of relevant platforms and devices by healthcare professionals is more likely, which benefits market expansion.
The increased prevalence of urological disorders like urinary tract infections, kidney stones, prostate enlargement, and bladder cancer significantly drives the need for urology care devices and platforms.
Moreover, the prevalence of these illnesses tends to rise as the world's population ages and lifestyles alter, which helps the market grow. The urology care devices and platforms market is highly competitive, with numerous established and emerging players vying for market share. Competition can lead to pricing pressure and profit margin constraints. Additionally, mergers and acquisitions in the industry may reduce the number of independent players, potentially limiting market choices for consumers.
Competitive Landscape:
Some major key players in the Urology Care Devices and Platforms Market:
- Avenida Health
- B. Braun Melungeon AG
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Cook Group
- Fresenius Medical Care AG & Co.
- Kagan
- Intuitive Surgical, Inc
- KARL STORZ SE & Co KG
- Lucida Medical Ltd
- Medtronic plc,
- Pox HealthCare Ltd.
- Richard Wolf GmbH
- Roamed
- Urologic, LLC.
- Axonics Modulation Technologies, Inc.
- Valencia Technologies Corporation
- NanoVibronix, Inc.
- I-O Urology
- CareLogiQ Corp.
- Renalytix AI plc
Market Segmentation:
The urology care devices and platforms market is segmented based on product, application, indication, and end users. Based on product, the urology care devices and platforms market is segmented into devices and platforms. By application, the urology care devices and platforms market are segmented into treatment diagnosis and Monitoring. By Indications, the market is segmented as pelvic organ prolapse, kidney diseases, urological cancer, benign prostatic hyperplasia and other diseases. By End User segments the market into hospitals, ambulatory surgery centres, clinics, dialysis centres, and home care settings.
Based On End Users, The Hospital's Segment Is A Major Contributor To The Urology Care Devices And Platforms Market
The hospital's category will hold a major share in the global Urology Care Devices and Platforms market in 2022. Hospitals generally have the necessary infrastructure, skilled medical personnel, and resources to effectively incorporate and utilize urology care devices and platforms. Urology care devices and platforms have facilitated the shift towards minimally invasive procedures, which offer benefits such as shorter hospital stays, reduced recovery times, and improved patient comfort.
Hospitals are embracing these technologies to offer advanced treatment options to their patients. Public awareness campaigns and preventive health initiatives have increased patient awareness about urological health. Hospitals play a pivotal role in implementing screening programs, diagnosing conditions, and providing appropriate urology care, often involving specialized devices and platforms.
The Kidney Disease Segment Witnessed Growth At A Rapid Rate
The kidney diseases segment is projected to grow rapidly in the global urology care devices and platforms market. Increasing awareness about kidney health and the importance of regular check-ups have led to more people seeking medical attention for kidney-related issues, further driving the demand for urology care devices and platforms. As kidney diseases continue to be a significant global health concern, the urology care devices and platforms market is expected to experience sustained growth in response to the tremendous demand for innovative and effective solutions to diagnose, treat, and manage kidney conditions.
The North America Urology Care Devices And Platforms Market Holds A Significant Regional Share
The North America Urology Care Devices and Platforms Market is expected to register the largest market share in revenue soon. Conditions like diabetes and obesity, risk factors for several urological disorders, are rising in the American region. This also contributes to an increased demand for urology care devices and platforms. Key market players in this region continue to invest in R&D to launch innovative products, further stimulating market growth.
In addition, the Asia Pacific regional market is projected to grow tremendously in the global market due to government initiatives, growing environmental concerns, rapid industrialization, and increasing funding in various industries. European countries typically have robust healthcare systems with favourable reimbursement policies, making urology care devices and platforms more accessible to patients.
Urology Care Devices and Platforms Market Report Scope:
Report Attribute |
Specifications |
Market Size Value In 2022 |
USD 16.25 Bn |
Revenue Forecast In 2031 |
USD 33.05 Bn |
Growth Rate CAGR |
CAGR of 8.3 % from 2023 to 2031 |
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
Historic Year |
2019 to 2022 |
Forecast Year |
2023-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Product, Application, Indication, End-User |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
Avenida Health, B. Braun Melungeon AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group, Fresenius Medical Care AG & Co. Kagan, Intuitive Surgical, Inc., KARL STORZ SE & Co KG, Lucida Medical Ltd, Medtronic plc, Pox HealthCare Ltd., Richard Wolf GmbH, Roamed, Urologic, LLC., Axonics Modulation Technologies, Inc., Valencia Technologies Corporation, NanoVibronix, Inc., I-O Urology, CareLogiQ Corp., Renalytix AI plc |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |